U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 5220

1.
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro, Silva A. Arslanian, David A. Ehrmann, Kathleen M. Hoeger, M. Hassan Murad, Renato Pasquali, Corrine K. Welt
J Clin Endocrinol Metab. 2013 Dec; 98(12): 4565–4592. Published online 2013 Nov 20. doi: 10.1210/jc.2013-2350
Correction in:
J Clin Endocrinol Metab. 2021 Jun; 106(6): e2462.
PMCID:
PMC5399492
ArticlePubReaderCite
2.
Chronic endometritis incidence in infertile women with and without polycystic ovary syndrome: a propensity score matched study
Jiayi Guo, Yajie Chang, Zhi Zeng, Huijun Liu, Xiaoyan Liang, Haitao Zeng, Jintao Peng
BMC Womens Health. 2023; 23: 628. Published online 2023 Nov 27. doi: 10.1186/s12905-023-02759-5
PMCID:
PMC10683087
ArticlePubReaderPDF–1.0MCite
3.
Нейроэндокринные особенности патогенеза синдрома поликистозных яичников (обзор литературы)
Абсатарова Ю. С., Евсеева Ю. С., Андреева Е. Н.
Probl Endokrinol (Mosk) 2023; 69(5): 107–114. Russian. Published online 2023 Nov 12. doi: 10.14341/probl13350
PMCID:
PMC10680539
ArticlePubReaderPDF–165KCite
4.
Assessment of health literacy in patients with polycystic ovary syndrome and its relationship with health behaviours: a cross-sectional study
Ying Liu, Yunmei Guo, Xin Yan, Rui Ding, Huiwen Tan, Yousha Wang, Xueting Wang, Lianhong Wang
BMJ Open. 2023; 13(11): e071051. Published online 2023 Nov 24. doi: 10.1136/bmjopen-2022-071051
PMCID:
PMC10680007
ArticlePubReaderPDF–388KCite
5.
Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
Leili Rahmatnezhad, Lida Moghaddam-Banaem, Tahereh Behroozi-Lak, Afshin Shiva, Javad Rasouli
Reprod Biol Endocrinol. 2023; 21: 113. Published online 2023 Nov 25. doi: 10.1186/s12958-023-01160-z
PMCID:
PMC10675950
ArticlePubReaderPDF–1.1MCite
6.
Progress of the application clinical prediction model in polycystic ovary syndrome
Guan Guixue, Pu Yifu, Gao Yuan, Liu Xialei, Shi Fan, Sun Qian, Xu Jinjin, Zhang Linna, Zhang Xiaozuo, Feng Wen, Yang Wen
J Ovarian Res. 2023; 16: 230. Published online 2023 Nov 25. doi: 10.1186/s13048-023-01310-2
PMCID:
PMC10675861
ArticlePubReaderPDF–1.2MCite
7.
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež, Mojca Jensterle
Life (Basel) 2023 Nov; 13(11): 2124. Published online 2023 Oct 26. doi: 10.3390/life13112124
PMCID:
PMC10672473
ArticlePubReaderPDF–670KCite
8.
Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome
Chen-Hua Zhang, Xiang-Yi Liu, Jing Wang
Int J Mol Sci. 2023 Nov; 24(22): 16247. Published online 2023 Nov 13. doi: 10.3390/ijms242216247
PMCID:
PMC10671516
ArticlePubReaderPDF–3.7MCite
9.
Early Life Factors and Polycystic Ovary Syndrome in a Swedish Birth Cohort
Beata Vivien Boldis, Ilona Grünberger, Agneta Cederström, Jonas Björk, Anton Nilsson, Jonas Helgertz
Int J Environ Res Public Health. 2023 Nov; 20(22): 7083. Published online 2023 Nov 20. doi: 10.3390/ijerph20227083
PMCID:
PMC10671095
ArticlePubReaderPDF–685KCite
10.
Association of Mitochondrial Variants with the Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis
Natalia Zeber-Lubecka, Maria Kulecka, Katarzyna Suchta, Michalina Dąbrowska, Michał Ciebiera, Ewa E. Hennig
Antioxidants (Basel) 2023 Nov; 12(11): 1983. Published online 2023 Nov 8. doi: 10.3390/antiox12111983
PMCID:
PMC10669137
ArticlePubReaderPDF–1.3MCite
11.
Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials
Dorina Ujvari, Anastasia Trouva, Angelica Lindén Hirschberg, Eszter Vanky
BMJ Open. 2023; 13(11): e073619. Published online 2023 Nov 21. doi: 10.1136/bmjopen-2023-073619
PMCID:
PMC10668301
ArticlePubReaderPDF–573KCite
12.
Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index
Gislaine Satyko Kogure, Victor Barbosa Ribeiro, Maria Célia Mendes, Rui Alberto Ferriani, Cristiana Libardi Miranda Furtado, Rosana Maria dos Reis
Arch Endocrinol Metab. 2023; 67(5): e000627. Published online 2023 May 29. doi: 10.20945/2359-3997000000627
PMCID:
PMC10665059
ArticlePubReaderPDF–286KCite
13.
Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study
Dushyanth Srinivasan, Holly F. Lofton
Obes Pillars. 2022 Jun; 2: 100016. Published online 2022 Apr 10. doi: 10.1016/j.obpill.2022.100016
PMCID:
PMC10661916
ArticlePubReaderPDF–234KCite
14.
Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair
Xinghua Li, Ihsan Ullah, Chunxia Hou, Yuqiang Liu, Keyuan Xiao
Medicine (Baltimore) 2023 Nov 17; 102(46): e36118. Published online 2023 Nov 17. doi: 10.1097/MD.0000000000036118
PMCID:
PMC10659600
ArticlePubReaderPDF–1.2MCite
15.
The effect of calorie-restriction along with thylakoid membranes of spinach on the gut-brain Axis Pathway and oxidative stress biomarkers in obese women with polycystic ovary syndrome: a Randomized, Double-blind, placebo-controlled clinical trial
Negin Nikrad, Mahdieh Abbasalizad Farhangi, Fatemeh Pourteymour Fard Tabrizi, Maryam Vaezi, Ata Mahmoudpour, Mehran Mesgari-Abbasi
J Ovarian Res. 2023; 16: 216. Published online 2023 Nov 16. doi: 10.1186/s13048-023-01288-x
PMCID:
PMC10652637
ArticlePubReaderPDF–1.4MCite
16.
Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis
Runxiang Cao, Lanlan Chen, Yutong Liu, Xuyutian Wang, Ruolin Ma, Qian Zhao, Ye Du
J Ovarian Res. 2023; 16: 215. Published online 2023 Nov 13. doi: 10.1186/s13048-023-01306-y
PMCID:
PMC10644512
ArticlePubReaderPDF–2.3MCite
17.
Machine learning classification of polycystic ovary syndrome based on radial pulse wave analysis
Jiekee Lim, Jieyun Li, Xiao Feng, Lu Feng, Yumo Xia, Xinang Xiao, Yiqin Wang, Zhaoxia Xu
BMC Complement Med Ther. 2023; 23: 409. Published online 2023 Nov 13. doi: 10.1186/s12906-023-04249-5
PMCID:
PMC10644435
ArticlePubReaderPDF–3.2MCite
18.
Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS)
Mahta Hadidi, Keyvan Karimabadi, Elham Ghanbari, Leila Rezakhani, Mozafar Khazaei
Front Endocrinol (Lausanne) 2023; 14: 1269266. Published online 2023 Oct 17. doi: 10.3389/fendo.2023.1269266
PMCID:
PMC10642184
ArticlePubReaderPDF–3.1MCite
19.
Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome
Shuwen Chen, Zaixin Guo, Qi Yu
Hum Genomics. 2023; 17: 100. Published online 2023 Nov 13. doi: 10.1186/s40246-023-00550-z
PMCID:
PMC10641977
ArticlePubReaderPDF–2.7MCite
20.
Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome
Anjali Agrawal, IV, Apoorva Dave, Arpita Jaiswal
Cureus. 2023 Oct; 15(10): e46859. Published online 2023 Oct 11. doi: 10.7759/cureus.46859
PMCID:
PMC10637759
ArticlePubReaderPDF–363KCite

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center